UNSPSC 85892256: High dose rate (hdr) brachytherapy of nose using californium 252 (cf-252)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of high dose rate (hdr) brachytherapy of nose using californium 252 (cf-252). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code D9119CZ

UNSPSC 85892256 High dose rate (hdr) brachytherapy of nose using californium 252 (cf-252) is a Commodity code that shows no relevant recent state and local procurement activity. The single recent opportunity posted under this code—County of Santa Clara Health System solicitation RFSQHHSFY270052, due October 7, 2026—is for temporary health professional staffing services across ancillary clinical categories including audiology, cardiology, diagnostic imaging, gastroenterology, ophthalmology, orthopedic services, respiratory care, sterile processing, surgical/operating room, and therapy services. This staffing solicitation bears no relation to the specialized oncology procedure the code nominally describes, indicating a classification mismatch rather than active market demand for brachytherapy services under this UNSPSC identifier.

The mismatch between code definition and posted opportunity limits actionability. State and local procurement officers may be using this code incorrectly for health staffing services, or the code may rarely appear in state and local solicitations because brachytherapy is typically procured through hospital systems' clinical service contracts, equipment leases, or radioactive materials handling frameworks outside standard vendor pools. Business development professionals targeting specialized oncology services should verify code assignment with customer procurement offices before assuming this UNSPSC reflects active buying intent.